Tuesday, November 01, 2011

Cert denied in Merck/Teva Temodar case

The US Supreme Court denied cert in the Temodar case thus allowing Merck & Co. to block Teva Pharmaceutical Industries Ltd. from selling a generic form of the brain-cancer drug Temodar until 2013.

0 Comments:

Post a Comment

<< Home